Published in Ann Thorac Surg on March 01, 2011
Primary and metastatic cardiac sarcomas: a 12-year experience at a German heart center. Int J Clin Exp Pathol (2012) 1.13
Primary cardiac sarcoma presenting as acute left-sided heart failure. J Community Hosp Intern Med Perspect (2014) 0.91
Clinical implication of surgical resection for the rare cardiac tumors involving heart and great vessels. J Korean Med Sci (2013) 0.84
Total Artificial Heart Implantation after Excision of Right Ventricular Angiosarcoma. Tex Heart Inst J (2016) 0.79
Case Report: Cardiac Tumor Resection And Repair With Porcine Xenograft. Methodist Debakey Cardiovasc J (2016) 0.78
Significant response to oral Etoposide in the treatment of an unresectable cardiac sarcoma. J Pediatr Hematol Oncol (2014) 0.78
Primary cardiac malignant fibrous histiocytoma with vulvar metastases: A case report. Oncol Lett (2015) 0.75
Case Report: A Rare Case of Left Atrial Hemangioma: Surgical Resection and Reconstruction. Methodist Debakey Cardiovasc J (2016) 0.75
Invited commentary. Ann Thorac Surg (2011) 0.75
Right Atrial Tumor Resection and Reconstruction with Use of an Acellular Porcine Bladder Membrane. Tex Heart Inst J (2016) 0.75
Survival after heart transplantation for non-metastatic primary cardiac sarcoma. J Cardiothorac Surg (2016) 0.75
An extremely rare case of a high-grade pleomorphic cardiac sarcoma and likely cerebral metastasis in a young patient. Ecancermedicalscience (2016) 0.75
Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med (2014) 5.88
Management of primary pulmonary artery sarcomas. Ann Thorac Surg (2009) 3.37
Loss of C. elegans BBS-7 and BBS-8 protein function results in cilia defects and compromised intraflagellar transport. Genes Dev (2004) 3.21
Derivation and validation of a preoperative prediction rule for delirium after cardiac surgery. Circulation (2008) 3.06
Primary cardiac tumors. Tex Heart Inst J (2011) 3.06
Doppler estimation of left ventricular filling pressures in patients with mitral valve disease. Circulation (2005) 2.79
Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol (2011) 2.70
Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg (2004) 2.62
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer (2005) 2.49
Factors associated with primary graft failure after heart transplantation. Transplantation (2010) 2.38
Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies. J Clin Oncol (2013) 2.27
Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma. J Thorac Oncol (2013) 2.22
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg (2004) 2.18
Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size. Ann Thorac Surg (2013) 2.15
Increased myocardial gene expression of tumor necrosis factor-alpha and nitric oxide synthase-2: a potential mechanism for depressed myocardial function in hibernating myocardium in humans. Circulation (2002) 2.11
Outcomes after surgical resection of cardiac sarcoma in the multimodality treatment era. J Thorac Cardiovasc Surg (2009) 2.07
Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer (2005) 2.04
Treatment outcomes of resected esophageal cancer. Ann Surg (2002) 2.03
A Semantic Web management model for integrative biomedical informatics. PLoS One (2008) 2.02
Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications. Ann Thorac Surg (2007) 2.01
Sarcomatoid carcinoma of the lung: a predictor of poor prognosis. Ann Thorac Surg (2007) 1.79
Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer (2007) 1.73
Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg (2005) 1.72
Surgical outcome in 85 patients with primary cardiac tumors. Am J Surg (2003) 1.72
Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg (2002) 1.64
Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys (2005) 1.63
The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer (2006) 1.63
Safety and efficacy of a novel gel for vascular occlusion in off-pump surgery. Ann Thorac Surg (2005) 1.61
Factors dominating choice of surgical specialty. J Am Coll Surg (2010) 1.60
Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res (2004) 1.57
Outcomes before and after initiation of an acute aortic treatment center. J Vasc Surg (2010) 1.56
Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol (2007) 1.56
Cardiac autotransplantation for primary cardiac tumors. Ann Thorac Surg (2006) 1.55
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol (2006) 1.55
Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg (2007) 1.54
Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Am J Surg Pathol (2007) 1.52
The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy. Ann Thorac Surg (2012) 1.51
Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol (2004) 1.49
Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg (2005) 1.49
Growth of a left atrial sarcoma followed by resection and autotransplantation. Ann Thorac Surg (2005) 1.48
Characteristics and function of cryopreserved bone marrow-derived endothelial progenitor cells. Ann Thorac Surg (2008) 1.47
Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation (2007) 1.47
Surgical treatment of primary cardiac sarcomas. Tex Heart Inst J (2009) 1.46
Renal cell carcinoma, metastatic to the left ventricle. Tex Heart Inst J (2009) 1.46
Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys (2003) 1.45
Transaortic resection of an apical left ventricular fibroelastoma facilitated by a thoracoscope. J Thorac Cardiovasc Surg (2007) 1.45
Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer (2011) 1.43
Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol (2004) 1.43
Increased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients. Ann Thorac Surg (2006) 1.42
Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma. Mol Cancer Ther (2006) 1.41
Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer (2005) 1.40
Management of primary cardiac sarcomas. Expert Rev Cardiovasc Ther (2008) 1.40
A loop technique for the safe, secure, and convenient fixation of subclavian central venous catheters to the chest wall. Am J Surg (2003) 1.40
Lung cancer after heart transplantation: a 17-year experience. Ann Thorac Surg (2005) 1.39
The relative importance of the deep and superficial vascular systems for delay of the transverse rectus abdominis musculocutaneous flap as demonstrated in a rat model. Plast Reconstr Surg (2002) 1.39
Venous interruption is unnecessary to achieve an adequate delay in the rat TRAM flap model. Plast Reconstr Surg (2003) 1.38
Non-small cell lung cancer resection in lymphoma patients. Ann Thorac Surg (2010) 1.38
Initial clinical experience of total cardiac replacement with dual HeartMate-II axial flow pumps for severe biventricular heart failure. Methodist Debakey Cardiovasc J (2011) 1.37
Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol (2005) 1.36
Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res (2003) 1.32
Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res (2004) 1.32
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys (2007) 1.28